Clinical Trial Update: National Survey on Dyslipidemic Patients

View source ↗

Summary

AstraZeneca-sponsored clinical trial survey of dyslipidemia patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidemia | Status: COMPLETED